Abstract
Cancer Prostate is the second most common cancer observed in males. As the age advances, risk to develop Cancer Prostate in males also increases. When the diseases advances to secondary metastases to various organs, nothing much can be done except palliative chemotherapy and radiotherapy. People are not yet aware that Ayurved, the oldest system of Indian Medicine can stop the progress of disease process and may cure the advanced cancer.
Case Report: A 66 year old male was detected Cancer Prostate with secondary metastases in Feb 2019. His PSA value was 134 ng/ml. His bilateral orchiectemy was done and was offered palliative chemotherapy and radiotherapy. His daughter, who was an Ayurvedic student approached Ayurved system of Indian Medicine and was treated successfully by Abhantar chikitsa and Panchkarma including Uttarbasti. He became totally free of symptoms within 4 months of Ayurvedic treatment. His PSA value returned to normal, i.e.0.266 ng/ml. He is totally free of disease for last 3 years and leading normal life with full quality of life.
Conclusion: Ayurved has strength and ability to treat Advanced cancer and this case report is the ray of hope to millions of sufferers of cancer.
Keywords: Cancer prostate, Secondary metastases, Asthila arbud, PSA value, Ayurvedic management.
References
- Prashanth Rawla. Review: Epidemiologist of Prostate Cancer. World Journal of Oncology. Volume 10, Number 2, April 2019: 63-89
- Rajgopal Shenoy and Anitha Shenoy. Chapter 41 Prostate and Seminal vesicles in Manipal Manual of Surgery. CBS Publishers and distributors Pvt. Ltd, New Delhi. 4th Edition 2014:972-980
- Jahn JL, Giovannucci EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer. 2015 Dec 15;137(12):2795-802. doi: 10.1002/ijc.29408. Epub 2015 Jan 8. PMID: 25557753; PMCID: PMC4485977.
- Jang JY, Kim YS. Is prostate biopsy essential to diagnose prostate cancer in the older patient with extremely high prostate-specific antigen? Korean J Urol. 2012 Feb;53(2):82-6. doi: 10.4111/kju.2012.53.2.82. Epub 2012 Feb 20. PMID: 22379585; PMCID: PMC3285713.
- Orchiectomy for Prostate Cancer. https://www.healthlinkbc.ca/health-topics/orchiectomy-prostate-cancer#:~:text=Orchiectomy%20is%20the%20removal%20of,in%20order%20to%20continue%20growing.
- Stage 4 Prostate cancer. https://www.mayoclinic.org/diseases-conditions/stage-4-prostate-cancer/diagnosis-treatment/drc-20377972
- Prostate cancer-Stages and grades. https://www.cancer.net/cancer-types/prostate-cancer/stages-and-grades#:~:text=The%20Gleason%20scoring%20system%20is,cells%20receive%20a%20low%20score.
- Gleason grading system. https://medlineplus.gov/ency/patientinstructions/000920.htm#:~:text=Gleason%20Score&text=When%20looking%20at%20cells%20under,almost%20like%20normal%20prostate%20cells
- Bramhanand Tripathi Commentator Charak Sanhita Vol.2. Hindi medium. Chaukhamba Surbharati Prakashan, Varanasi-221 001. 2015. Chikitsa sthan Chapter 12, verse 81:459-460
- Anantram Sharma. Commentator. Sushruta Sanhita. Vol.1 Hindi medium. Chaukhamba Surbharati Prakashan, Varanasi-221 001.2015. Nidan sthan. Chapter 11, verse 14:542
- Ganesh Krishna Garde. Commentator. Sarth Vagbhat. Marathi medium. Chaukhamba Surbharati Prakashan, Varanasi-221 001.2015.Uttarsthan. Chapter 29, verse 2:441
- Anantram Sharma. Commentator. Sushruta Sanhita. Vol.1 Hindi medium. Chaukhamba Surbharati Prakashan, Varanasi-221 001.2015. Nidan sthan. Chapter 11, verse 20
- Vaidya P.Y.Khadiwale. Yashaswi Ayurvediya Aushadhikaran: Shashtra-Vyavahara. Marathi medium. Khadiwale Sanshodhan Santha (Regd), Pune. Publisher Mrs. Sangita Vaidya. Pune-411 030. 2008:185-186
Corresponding Author
Dr Sarita Pradip Gaikwad
M.D. (Manas rog), PhD (Kayachikitsa),
Director, Punarnava Trimarma Chikitsalay and Research Centre, Nanded-431 602
Ex HoD Ayurved Research Department, Sassoon Hospital, Pune-411 001 and Vol. Retd. Assistant Director, AYUSH, Pune region, Pune
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.